Condition: Ischemic Stroke, Acute · Rehabilitation Outcome · Cerebrolysin · Sponsor: University Medical Centre Ljubljana
The study evaluates the effect and safety of Cerebrolysin administered during early rehabilitation in patients with moderate neurological impairment after acute ischemic stroke, conducted at the Department of Vascular Neurology and Intensive Neurological Therapy, UMC Ljubljana.
This description comes directly from the study's public registry record.
Matija Zupan, MD, PhD · 0038615229581 · matija.zupan@kclj.si
Marjan Zaletel, MD, PhD · 0038615227115 · marjan.zaletel@kclj.si
Always discuss trial participation with your own doctor first.
| UMC Ljubljana - Department of Vascular Neurology and Intensive Neurological Therapy (KOVNINT) | Ljubljana, Slovenia | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07043686